Global Transfection Technologies Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Transfection technology is used in the production of exogenous nucleic acids such as DNA, RNA and oligonucleotide in the body cell. The transfection technology methods are widely used in genomic studies such as in vitro research, cell representation and RNA interference. Also, Transfection Technologies are used for treating injuries and illnesses that need immediate care. The Increase in prevalence of diseases, new products launches has led to the adoption of Transfection Technologies across the forecast period. For Instance: In December 2018, Polyplus-transfection SA declared the release of PEIpro-GMP, a transfection reagent for medical and industrial lentivirus and adeno-associated disease (AAV) tissue & DNA therapy. Also, with the cost-effectiveness and less complicated methods, the adoption & demand for Transfection Technologies is likely to increase the market growth during the forecast period. However, high costs related to the transfection technology instruments impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Transfection Technologies Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the rise in funding for research and development in transfection technology. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as increase in the prevalence of diseases such as cancer and obesity would create lucrative growth prospects for the Transfection Technologies Market across Asia-Pacific region.
Major market players included in this report are:
PromoKine gmbh
Thermo Fisher Scientific
Sigma Aldrich
Promega Corporation
Lonza
Roche
Qiagen
Polyplus Transfection
MaxCyte
Mirus Bio
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Transfection Method:
Instrument Based Method
Reagent Based Method
Virus Based Method
By Application:
Bio-medical Research
Therapeutic Delivery
Protein Production
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Transfection Technologies Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
- 1.2.1. Global Transfection Technologies Market, by Region, 2020-2028 (USD Billion)
- 1.2.2. Global Transfection Technologies Market, by Transfection Method, 2020-2028 (USD Billion)
- 1.2.3. Global Transfection Technologies Market, by Application, 2020-2028 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Transfection Technologies Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Transfection Technologies Market Dynamics
- 3.1. Transfection Technologies Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Increase in prevalence of diseases
- 3.1.1.2. New products launch
- 3.1.2. Market Challenges
- 3.1.2.1. High costs related to the transfection technology instruments
- 3.1.3. Market Opportunities
- 3.1.3.1. Cost-effectiveness and less complicated methods
Chapter 4. Global Transfection Technologies Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Transfection Technologies Market, by Transfection Method
- 6.1. Market Snapshot
- 6.2. Global Transfection Technologies Market by Transfection Method, Performance - Potential Analysis
- 6.3. Global Transfection Technologies Market Estimates & Forecasts by Transfection Method, 2019-2028 (USD Billion)
- 6.4. Transfection Technologies Market, Sub Segment Analysis
- 6.4.1. Instrument Based Method
- 6.4.2. Reagent Based Method
- 6.4.3. Virus Based Method
Chapter 7. Global Transfection Technologies Market, by Application
- 7.1. Market Snapshot
- 7.2. Global Transfection Technologies Market by Application, Performance - Potential Analysis
- 7.3. Global Transfection Technologies Market Estimates & Forecasts by Application, 2019-2028 (USD Billion)
- 7.4. Transfection Technologies Market, Sub Segment Analysis
- 7.4.1. Bio-medical Research
- 7.4.2. Therapeutic Delivery
- 7.4.3. Protein Production
Chapter 8. Global Transfection Technologies Market, Regional Analysis
- 8.1. Transfection Technologies Market, Regional Market Snapshot
- 8.2. North America Transfection Technologies Market
- 8.2.1. U.S. Transfection Technologies Market
- 8.2.1.1. Transfection Method breakdown estimates & forecasts, 2019-2028
- 8.2.1.2. Application breakdown estimates & forecasts, 2019-2028
- 8.2.2. Canada Transfection Technologies Market
- 8.3. Europe Transfection Technologies Market Snapshot
- 8.3.1. U.K. Transfection Technologies Market
- 8.3.2. Germany Transfection Technologies Market
- 8.3.3. France Transfection Technologies Market
- 8.3.4. Spain Transfection Technologies Market
- 8.3.5. Italy Transfection Technologies Market
- 8.3.6. Rest of Europe Transfection Technologies Market
- 8.4. Asia-Pacific Transfection Technologies Market Snapshot
- 8.4.1. China Transfection Technologies Market
- 8.4.2. India Transfection Technologies Market
- 8.4.3. Japan Transfection Technologies Market
- 8.4.4. Australia Transfection Technologies Market
- 8.4.5. South Korea Transfection Technologies Market
- 8.4.6. Rest of Asia Pacific Transfection Technologies Market
- 8.5. Latin America Transfection Technologies Market Snapshot
- 8.5.1. Brazil Transfection Technologies Market
- 8.5.2. Mexico Transfection Technologies Market
- 8.6. Rest of The World Transfection Technologies Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. PromoKine gmbh
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. Product Summary
- 9.2.1.5. Recent Developments
- 9.2.2. Thermo Fisher Scientific
- 9.2.3. Sigma Aldrich
- 9.2.4. Promega Corporation
- 9.2.5. Lonza
- 9.2.6. Roche
- 9.2.7. Qiagen
- 9.2.8. Polyplus Transfection
- 9.2.9. MaxCyte
- 9.2.10. Mirus Bio
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption